Q4433 HCPCS Reimbursement & Policy Benchmarks

HCPCS Level II code Q4433 identifies a 361 hct/p skin substitute product billed in addition to a primary surgical or wound-care procedure. As an ancillary supply code, it matters nationally because skin substitute products affect procedure costs, supply chain management, and payer coverage policies across hospital, ambulatory surgery, and wound-care settings. Clear coding supports accurate reimbursement and appropriate utilization monitoring.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines which payers commonly cover skin substitute adjuncts, how they classify these products for claims processing, and typical sites of service where Q4433 is applied.

Readers will learn clinical and billing context for Q4433, including its role as an adjunct skin substitute product, typical settings of use, and the implications for billing lines and facility reporting. The overview provides benchmarks for payers listed above where available, summarizes relevant policy themes affecting coverage and coding of skin substitutes, and highlights documentation elements and claim-line considerations. Data not available in the input will be noted where applicable.

Billing Code Overview

HCPCS Level II code Q4433 describes a 361 hct/p skin substitute product, not otherwise specified (list in addition to primary procedure). This code represents an additional billed skin substitute material used to support wound care or reconstructive procedures when a primary procedure code is reported separately.

Service type: Skin substitute product used as an adjunct to a primary procedure

Typical site of service: Inpatient or outpatient surgical settings, hospital clinics, wound care centers, and ambulatory surgical centers

Data not available in the input.

Clinical Context

A 68-year-old patient with a chronic, non-healing lower extremity wound after peripheral vascular disease and prior debridement presents to an outpatient wound care clinic. After assessment, the provider elects to apply a human-derived or synthetic skin substitute product as an adjunct to standard wound care to promote granulation and re-epithelialization. The clinical workflow includes wound measurement and photography, wound bed preparation (debridement and hemostasis as needed), selection and thawing/preparation of the skin substitute, application and fixation of the product to the wound, and placement of an appropriate dressing. The procedure is documented in the clinic note with product name, lot number, size applied, and whether the skin substitute is supplied by the facility or brought in by the patient. Follow-up visits are scheduled to monitor wound progress and change dressings; additional applications of the skin substitute may be coded separately when clinically indicated.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When work or complexity is substantially greater than typical for the primary procedure accompanying the skin substitute application.
`26`	Professional component

Taxonomy Code	Specialty	Notes
`207P00000X`	Podiatry	Podiatrists commonly manage chronic foot and lower-extremity wounds and apply skin substitutes.
`207L00000X`	Vascular Surgery	Vascular surgeons treat ischemic wounds and perform wound bed optimization prior to skin substitute placement.
`207K00000X`	General Surgery	General surgeons manage complex soft-tissue wounds and may apply skin substitutes in clinic or OR.
`207RC0000X`	Family Medicine	Family physicians with wound care training may perform skin substitute applications in outpatient wound clinics.
`207WF0002X`	Wound Care/Hyperbaric Medicine	Wound care specialists and hyperbaric physicians direct comprehensive wound programs including skin substitute use.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.321`	Non-pressure chronic ulcer of right calf with necrosis of muscle	Chronic lower-extremity ulcer that may require skin substitute application after debridement and vascular optimization.
`L97.322`	Non-pressure chronic ulcer of left calf with necrosis of muscle	Contralateral chronic ulcer example relevant to similar use of skin substitutes.
`I70.239`	Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity	Peripheral arterial disease contributing to poor wound healing; vascular assessment and optimization are part of the workflow when using skin substitutes.
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers are a frequent indication for skin substitute products to promote healing.
`L89.153`	Pressure ulcer of sacral region, stage 3	Pressure injuries with full-thickness skin loss commonly treated with advanced wound therapies including skin substitutes.
`T79.A11`	Post-traumatic wound infection of right lower limb	Traumatic wounds with infection may be managed with debridement and staged skin substitute application after infection control.
`L98.4`	Chronic ulcer of other sites, not elsewhere classified	Miscellaneous chronic wounds that may be treated with skin substitute products.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue, first 20 sq cm or less	Surgical debridement of devitalized tissue commonly performed prior to placement of a skin substitute to prepare the wound bed.
`11043`	Debridement, muscle and/or fascia, first 20 sq cm or less	Deeper debridement that may be necessary before skin substitute application in wounds involving muscle or fascia.
`29581`	Application of skin substitute graft to foot and/or ankle, non-meshed, non-expanded, first 30 sq cm or less	Represents application of a skin substitute to foot/ankle wounds; used when CPT descriptive codes are available and applicable alongside HCPCS billing for product.
`15271`	Application of biologic dressing to trunk or extremity, first 25 sq cm or less	Codes for placement of biologic dressings/skin substitutes to larger areas in operative or clinic settings; may be used in related workflows.
`97597`	Debridement (selective) by skilled professional; initial wound management, first 20 sq cm or less	Non-surgical sharp debridement by a skilled provider in outpatient setting prior to or concurrent with skin substitute application.

OpenPayer

Summary & Overview

HCPCS Q4433: 361 HCT/P Skin Substitute Product, Adjunct